XPACE-2004

Pipeline Category

Pharmaceutical

Short Description / Indication

XPACE-2004 (also written as XPACE 2004) is an investigational mRNA prophylactic vaccine developed by Xanadu Bio to protect against Respiratory Syncytial Virus (RSV) infections

Areas of Focus

Therapeutics & Vaccines

Licensees

Company Name	Company Website URL
Xanadu Bio	https://xanadubio.com/

Pharmaceutical Status

Preclinical